ArticleBrain : a journal of neurology2026

PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease models.

Eduardo A Albornoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.